BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1825900)

  • 1. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis.
    Caro JJ; Trindade E; McGregor M
    AJR Am J Roentgenol; 1991 Apr; 156(4):825-32. PubMed ID: 1825900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
    Henry DA; Evans DB; Robertson J
    Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media.
    Caro JJ; Trindade E; McGregor M
    AJR Am J Roentgenol; 1992 Oct; 159(4):869-74. PubMed ID: 1529856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.
    Steinberg EP; Moore RD; Powe NR; Gopalan R; Davidoff AJ; Litt M; Graziano S; Brinker JA
    N Engl J Med; 1992 Feb; 326(7):425-30. PubMed ID: 1732769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision analysis to assess cost-effectiveness of low-osmolality contrast medium for intravenous urography.
    Calvo MV; Pilar del Val M; Mar Alvarez M; Domínguez-Gil A
    Am J Hosp Pharm; 1992 Mar; 49(3):577-84. PubMed ID: 1598930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intravascular low-osmolality contrast agents.
    Swanson DP; Thrall JH; Shetty PC
    Clin Pharm; 1986 Nov; 5(11):877-91. PubMed ID: 3780159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
    Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
    N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.
    Hunter TB; Dye J; Duval JF
    AJR Am J Roentgenol; 1994 Oct; 163(4):965-8. PubMed ID: 8092044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial.
    Barrett BJ; Parfrey PS; McDonald JR; Hefferton DM; Reddy ER; McManamon PJ
    Radiology; 1992 Apr; 183(1):105-10. PubMed ID: 1549654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
    Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
    Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonfatal adverse reactions to iodinated contrast media: spontaneous reporting to the U.S. Food and Drug Administration, 1978-1994.
    Spring DB; Bettmann MA; Barkan HE
    Radiology; 1997 Aug; 204(2):325-32. PubMed ID: 9240515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiocontrast media allergic reactions and interventional pain practice--a review.
    Newmark JL; Mehra A; Singla AK
    Pain Physician; 2012; 15(5):E665-75. PubMed ID: 22996860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of unenhanced MR imaging vs contrast-enhanced CT of the abdomen or pelvis.
    Lessler DS; Sullivan SD; Stergachis A
    AJR Am J Roentgenol; 1994 Jul; 163(1):5-9. PubMed ID: 8010246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactions to iodinated contrast media].
    Porri F; Vervloet D
    Allerg Immunol (Paris); 1994 Dec; 26(10):374-6, 379. PubMed ID: 7702729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous contrast media: use and associated mortality.
    Cashman JD; McCredie J; Henry DA
    Med J Aust; 1991 Nov; 155(9):618-23. PubMed ID: 1943961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-osmolality versus high-osmolality contrast material.
    Korn WT; Bettmann MA
    Curr Opin Radiol; 1992 Apr; 4(2):9-15. PubMed ID: 1554592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment.
    Bush WH; Swanson DP
    AJR Am J Roentgenol; 1991 Dec; 157(6):1153-61. PubMed ID: 1950858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions to contrast media: factors that determine the cost of treatment.
    Powe NR; Moore RD; Steinberg EP
    AJR Am J Roentgenol; 1993 Nov; 161(5):1089-95. PubMed ID: 8273616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication.
    Freed KS; Leder RA; Alexander C; DeLong DM; Kliewer MA
    AJR Am J Roentgenol; 2001 Jun; 176(6):1389-92. PubMed ID: 11373198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.